GL: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/5ab7b69e-c51a-4988-aa78-762fb86f8247/","filing_uuid":"5ab7b69e-c51a-4988-aa78-762fb86f8247","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5ab7b69e-c51a-4988-aa78-762fb86f8247/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Lindsay Austin","dt_posted":"2026-07-20T13:42:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"401 9th Street, N.W. Suite 1000","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":81511,"url":"https://lda.gov/api/v1/registrants/81511/","house_registrant_id":36579,"name":"TROUTMAN STRATEGIES","description":"Lobbying Firm","address_1":"401 9th Street, N.W. Suite 1000","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LINDSAY AUSTIN","contact_telephone":"+1 202-274-2865","dt_updated":"2026-07-29T12:48:27.497388-04:00"},"client":{"id":63629,"url":"https://lda.gov/api/v1/clients/63629/","client_id":63629,"name":"GLOBE LIFE, INC.","general_description":"Insurance Company","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues related to Medicare Supplemental Insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148251,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"ZANETTI","suffix":null,"suffix_display":null},"covered_position":"NONE","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to tax policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148251,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"ZANETTI","suffix":null,"suffix_display":null},"covered_position":"NONE","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}